Histamine H1 receptor antagonists have limited direct therapeutic value in cluster headache management. While they do not typically provide significant acute or preventive relief, some research suggests potential modulatory effects on neurogenic inflammation and vascular tone in trigeminal neurovascular pathways. Their primary pharmacological utility remains primarily symptomatic and adjunctive rather than a primary treatment strategy.